Search Results - "Won, Haejung"

  • Showing 1 - 15 results of 15
Refine Results
  1. 1

    TLR9-Targeted STAT3 Silencing Abrogates Immunosuppressive Activity of Myeloid-Derived Suppressor Cells from Prostate Cancer Patients by Hossain, Dewan M S, Pal, Sumanta K, Moreira, Dayson, Duttagupta, Priyanka, Zhang, Qifang, Won, Haejung, Jones, Jeremy, D'Apuzzo, Massimo, Forman, Stephen, Kortylewski, Marcin

    Published in Clinical cancer research (15-08-2015)
    “…Recent advances in immunotherapy of advanced human cancers underscored the need to address and eliminate tumor immune evasion. The myeloid-derived suppressor…”
    Get full text
    Journal Article
  2. 2

    TLR9 expression and secretion of LIF by prostate cancer cells stimulates accumulation and activity of polymorphonuclear MDSCs by Won, Haejung, Moreira, Dayson, Gao, Chan, Duttagupta, Priyanka, Zhao, Xingli, Manuel, Edwin, Diamond, Don, Yuan, Yate‐Ching, Liu, Zheng, Jones, Jeremy, D’Apuzzo, Massimo, Pal, Sumanta, Kortylewski, Marcin

    Published in Journal of leukocyte biology (01-08-2017)
    “…TLR9 upregulation in prostate cancer cells results in the LIF‐mediated recruitment and increased tolerogenic activity of polymorphonuclear myeloid‐derived…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Myeloid cell-targeted STAT3 inhibition sensitizes head and neck cancers to radiotherapy and T cell-mediated immunity by Moreira, Dayson, Sampath, Sagus, Won, Haejung, White, Seok Voon, Su, Yu-Lin, Alcantara, Marice, Wang, Chongkai, Lee, Peter, Maghami, Ellie, Massarelli, Erminia, Kortylewski, Marcin

    Published in The Journal of clinical investigation (19-01-2021)
    “…The tumor microenvironment affects the outcome of radiotherapy against head and neck squamous cell carcinoma (HNSCC). We recently found that tolerogenic…”
    Get full text
    Journal Article
  5. 5

    Serum-resistant CpG-STAT3 decoy for targeting survival and immune checkpoint signaling in acute myeloid leukemia by Zhang, Qifang, Hossain, Dewan Md Sakib, Duttagupta, Priyanka, Moreira, Dayson, Zhao, Xingli, Won, Haejung, Buettner, Ralf, Nechaev, Sergey, Majka, Marcin, Zhang, Bin, Cai, Qi, Swiderski, Piotr, Kuo, Ya-Huei, Forman, Stephen, Marcucci, Guido, Kortylewski, Marcin

    Published in Blood (31-03-2016)
    “…Targeting oncogenic transcription factor signal transducer and activator of transcription 3 (STAT3) in acute myeloid leukemia (AML) can reduce blast survival…”
    Get full text
    Journal Article
  6. 6

    Abstract 35: Chemo-radiotherapy induces tolerogenic STAT3 signaling in circulating myeloid-derived suppressor cells in patients with head and neck squamous cell carcinoma (HNSCC) by Won, Haejung, Sampath, Sagus, Massarelli, Erminia, Maghami, Ellie, Kortylewski, Marcin

    Published in Clinical cancer research (01-12-2017)
    “…Abstract Background and Objectives: While radiation therapy (RT) and certain types of chemotherapy are potentially immunogenic, they rarely generate antitumor…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Epigenetic control of dendritic cell development and fate determination of common myeloid progenitor by Mysm1 by Won, Haejung, Nandakumar, Vijayalakshmi, Yates, Peter, Sanchez, Suzi, Jones, Lindsey, Huang, Xue F., Chen, Si-Yi

    Published in Blood (23-10-2014)
    “…The mechanisms controlling the development of dendritic cells (DCs) remain incompletely understood. Using an Mysm1 knockout (Mysm1−/−) mouse model, we…”
    Get full text
    Journal Article
  9. 9

    Combined modality radiation therapy promotes tolerogenic myeloid cell populations and STAT3-related gene expression in head and neck cancer patients by Sampath, Sagus, Won, Haejung, Massarelli, Erminia, Li, Min, Frankel, Paul, Vora, Nayana, Vora, Lalit, Maghami, Ellie, Kortylewski, Marcin

    Published in Oncotarget (16-02-2018)
    “…Immunomodulation contributes to the antitumor efficacy of the fractionated radiation therapy (RT). Here, we describe immune effects of RT with concurrent…”
    Get full text
    Journal Article
  10. 10

    B Cell Lymphoma Immunotherapy Using TLR9-Targeted Oligonucleotide STAT3 Inhibitors by Zhao, Xingli, Zhang, Zhuoran, Moreira, Dayson, Su, Yu-Lin, Won, Haejung, Adamus, Tomasz, Dong, Zhenyuan, Liang, Yong, Yin, Hongwei H., Swiderski, Piotr, Pillai, Raju K., Kwak, Larry, Forman, Stephen, Kortylewski, Marcin

    Published in Molecular therapy (07-03-2018)
    “…Growing evidence links the aggressiveness of non-Hodgkin’s lymphoma, especially the activated B cell-like type diffuse large B cell lymphomas (ABC-DLBCLs) to…”
    Get full text
    Journal Article
  11. 11

    Association of microbiome and plasma cytokine dynamics to nivolumab response in metastatic renal cell carcinoma (mRCC) by Maia, Manuel C., Poroyko, Valeriy, Won, Haejung, Almeida, Lorena, Bergerot, Paulo Gustavo, Dizman, Nazli, Hsu, Joann, Jones, Jeremy, Salgia, Ravi, Pal, Sumanta K.

    Published in Journal of clinical oncology (20-02-2018)
    “…Abstract only 656 Background: Checkpoint inhibitors (CPI) represent a standard of care in mRCC. The relationship of the microbiome to benefit from CPIs has…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Control of B Cell Development by the Histone H2A Deubiquitinase MYSM1 by Jiang, Xiao-Xia, Nguyen, Quan, Chou, YuChia, Wang, Tao, Nandakumar, Vijayalakshmi, Yates, Peter, Jones, Lindsey, Wang, Lifeng, Won, Haejung, Lee, Hye-Ra, Jung, Jae U., Müschen, Markus, Huang, Xue F., Chen, Si-Yi

    Published in Immunity (Cambridge, Mass.) (23-12-2011)
    “…Epigenetic histone modifications play critical roles in the control of gene transcription. Recently, an increasing number of histone H2A deubiquitinases have…”
    Get full text
    Journal Article
  14. 14

    Gut microbiome composition and response to sunitinib in metastatic renal cell carcinoma (mRCC) by Gong, Jun, Dizman, Nazli, Poroyko, Valeriy, Won, Haejung, Bergerot, Cristiane Decat, Bergerot, Paulo Gustavo, Maia, Manuel C., Hsu, Joann, Frankel, Paul Henry, Jones, Jeremy, Salgia, Ravi, Pal, Sumanta K.

    Published in Journal of clinical oncology (20-02-2018)
    “…Abstract only 657 Background: Recent evidence supports a link between stool microbiome composition and immunotherapy response. However, it is unclear how the…”
    Get full text
    Journal Article
  15. 15

    Histone H2A deubiquitinase MYSM1 is essential for dendritic cell development (P4488) by Won, Haejung, Chou, Yuchia, Wang, Tao, Jones, Lindsey, Huang, Xue, Chen, Si-Yi

    Published in The Journal of immunology (1950) (01-05-2013)
    “…Abstract The mechanisms controlling differentiation of dendritic cells remain largely unknown. Using knockout mouse model, we identified Mysm1 as a critical…”
    Get full text
    Journal Article